U.S. flag

An official website of the United States government

NM_001370259.2(MEN1):c.1351-1G>C AND Multiple endocrine neoplasia, type 1

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Oct 15, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000540660.7

Allele description [Variation Report for NM_001370259.2(MEN1):c.1351-1G>C]

NM_001370259.2(MEN1):c.1351-1G>C

Gene:
MEN1:menin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q13.1
Genomic location:
Preferred name:
NM_001370259.2(MEN1):c.1351-1G>C
HGVS:
  • NC_000011.10:g.64804817C>G
  • NG_008929.1:g.11478G>C
  • NG_033040.1:g.3425G>C
  • NG_033040.2:g.3397G>C
  • NM_000244.4:c.1366-1G>C
  • NM_001370251.2:c.1477-1G>C
  • NM_001370259.2:c.1351-1G>CMANE SELECT
  • NM_001370260.2:c.1351-1G>C
  • NM_001370261.2:c.1351-1G>C
  • NM_001370262.2:c.1246-1G>C
  • NM_001370263.2:c.1246-1G>C
  • NM_001407142.1:c.1477-1G>C
  • NM_001407143.1:c.1477-1G>C
  • NM_001407144.1:c.1477-1G>C
  • NM_001407145.1:c.1366-1G>C
  • NM_001407146.1:c.1351-1G>C
  • NM_001407147.1:c.1351-1G>C
  • NM_001407148.1:c.1246-1G>C
  • NM_001407149.1:c.1246-1G>C
  • NM_001407150.1:c.1492-1G>C
  • NM_001407151.1:c.1372-1G>C
  • NM_001407152.1:c.1186-1G>C
  • NM_130799.3:c.1351-1G>C
  • NM_130800.3:c.1366-1G>C
  • NM_130801.3:c.1366-1G>C
  • NM_130802.3:c.1366-1G>C
  • NM_130803.3:c.1366-1G>C
  • NM_130804.3:c.1366-1G>C
  • LRG_509t2:c.1351-1G>C
  • LRG_509:g.11478G>C
  • NC_000011.9:g.64572289C>G
  • NM_130799.2:c.1351-1G>C
Links:
dbSNP: rs794728629
NCBI 1000 Genomes Browser:
rs794728629
Molecular consequence:
  • NM_000244.4:c.1366-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001370251.2:c.1477-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001370259.2:c.1351-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001370260.2:c.1351-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001370261.2:c.1351-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001370262.2:c.1246-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001370263.2:c.1246-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001407142.1:c.1477-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001407143.1:c.1477-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001407144.1:c.1477-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001407145.1:c.1366-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001407146.1:c.1351-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001407147.1:c.1351-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001407148.1:c.1246-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001407149.1:c.1246-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001407150.1:c.1492-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001407151.1:c.1372-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001407152.1:c.1186-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_130799.3:c.1351-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_130800.3:c.1366-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_130801.3:c.1366-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_130802.3:c.1366-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_130803.3:c.1366-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_130804.3:c.1366-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]

Condition(s)

Name:
Multiple endocrine neoplasia, type 1 (MEN1)
Synonyms:
MEA I; MEN I; Endocrine adenomatosis multiple; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007540; MeSH: D018761; MedGen: C0025267; Orphanet: 652; OMIM: 131100

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000628038Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Oct 15, 2019)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular pathology of multiple endocrine neoplasia type I: two novel germline mutations and updated classification of mutations affecting MEN1 gene.

Martín-Campos JM, Catasús L, Chico A, Mayoral C, Lagarda E, Gallart L, Mato E, Rodríguez-Espinosa J, Matías-Guiu X, De Leiva A, Blanco-Vaca F.

Diagn Mol Pathol. 1999 Dec;8(4):195-204.

PubMed [citation]
PMID:
10617276

Aberrant 5' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization.

Buratti E, Chivers M, Královicová J, Romano M, Baralle M, Krainer AR, Vorechovsky I.

Nucleic Acids Res. 2007;35(13):4250-63. Epub 2007 Jun 18.

PubMed [citation]
PMID:
17576681
PMCID:
PMC1934990
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000628038.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

For these reasons, this variant has been classified as Pathogenic. This sequence change affects an acceptor splice site in the last intron (intron 9) of the MEN1 gene. While this is not anticipated to result in nonsense mediated decay, it likely alters RNA splicing and results in a disrupted protein product. This variant is not present in population databases (ExAC no frequency). Disruption of this splice site has been observed in individuals affected with clinical features of multiple endocrine neoplasia type 1 (PMID: 10617276, Invitae). ClinVar contains an entry for this variant (Variation ID: 200985). Disruption of this splice site has been reported to affect MEN1 protein function (PMID: 17185897). Nucleotide substitutions within the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Experimental studies have shown that disruption of this splice site disrupts mRNA splicing (PMID: 17185897).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024